Literature DB >> 24055690

Superparamagnetic iron oxide nanoparticles (SPIONs)-loaded Trojan microparticles for targeted aerosol delivery to the lung.

Frederic Tewes1, Carsten Ehrhardt2, Anne Marie Healy3.   

Abstract

Targeted aerosol delivery to specific regions of the lung may improve therapeutic efficiency and minimise unwanted side effects. Targeted delivery could potentially be achieved with porous microparticles loaded with superparamagnetic iron oxide nanoparticles (SPIONs)-in combination with a target-directed magnetic gradient field. The aim of this study was to formulate and evaluate the aerodynamic properties of SPIONs-loaded Trojan microparticles after delivery from a dry powder inhaler. Microparticles made of SPIONs, PEG and hydroxypropyl-β-cyclodextrin (HPβCD) were formulated by spray drying and characterised by various physicochemical methods. Aerodynamic properties were evaluated using a next generation cascade impactor (NGI), with or without a magnet positioned at stage 2. Mixing appropriate proportions of SPIONs, PEG and HPβCD allowed Trojan microparticle to be formulated. These particles had a median geometric diameter of 2.8±0.3μm and were shown to be sensitive to the magnetic field induced by a magnet having a maximum energy product of 413.8kJ/m(3). However, these particles, characterised by a mass median aerodynamic diameter (MMAD) of 10.2±2.0μm, were considered to be not inhalable. The poor aerodynamic properties resulted from aggregation of the particles. The addition of (NH4)2CO3 and magnesium stearate (MgST) to the formulation improved the aerodynamic properties of the Trojan particles and resulted in a MMAD of 2.2±0.8μm. In the presence of a magnetic field on stage 2 of the NGI, the amount of particles deposited at this stage increased 4-fold from 4.8±0.7% to 19.5±3.3%. These Trojan particles appeared highly sensitive to the magnetic field and their deposition on most of the stages of the NGI was changed in the presence compared to the absence of the magnet. If loaded with a pharmaceutical active ingredient, these particles may be useful for treating localised lung disease such as cancer nodules or bacterial infectious foci.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aerodynamic; Aerosol; Lung; Magnetic targeting; NGI; SPION; Trojan microparticles

Mesh:

Substances:

Year:  2013        PMID: 24055690     DOI: 10.1016/j.ejpb.2013.09.004

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  10 in total

1.  Preparation and Characterization of Magnetic Nano-in-Microparticles for Pulmonary Delivery.

Authors:  Amber A McBride; Dominique N Price; Pavan Muttil
Journal:  Methods Mol Biol       Date:  2017

2.  Physicochemical characterization of nebulized superparamagnetic iron oxide nanoparticles (SPIONs).

Authors:  Halshka Graczyk; Louise C Bryan; Nastassja Lewinski; Guillaume Suarez; Geraldine Coullerez; Paul Bowen; Michael Riediker
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2014-05-06       Impact factor: 2.849

Review 3.  Nebulised antibiotherapy: conventional versus nanotechnology-based approaches, is targeting at a nano scale a difficult subject?

Authors:  Esther de Pablo; Raquel Fernández-García; María Paloma Ballesteros; Juan José Torrado; Dolores R Serrano
Journal:  Ann Transl Med       Date:  2017-11

4.  Formulation and characterization of inhalable magnetic nanocomposite microparticles (MnMs) for targeted pulmonary delivery via spray drying.

Authors:  Nathanael A Stocke; Samantha A Meenach; Susanne M Arnold; Heidi M Mansour; J Zach Hilt
Journal:  Int J Pharm       Date:  2014-12-24       Impact factor: 5.875

Review 5.  Drug-targeting methodologies with applications: A review.

Authors:  Clement Kleinstreuer; Yu Feng; Emily Childress
Journal:  World J Clin Cases       Date:  2014-12-16       Impact factor: 1.337

6.  Enhanced and selective delivery of enzyme therapy to 9L-glioma tumor via magnetic targeting of PEG-modified, β-glucosidase-conjugated iron oxide nanoparticles.

Authors:  Jie Zhou; Jian Zhang; Wenxi Gao
Journal:  Int J Nanomedicine       Date:  2014-06-10

7.  In Vivo Pulmonary Delivery and Magnetic-Targeting of Dry Powder Nano-in-Microparticles.

Authors:  Dominique N Price; Loreen R Stromberg; Nitesh K Kunda; Pavan Muttil
Journal:  Mol Pharm       Date:  2017-11-09       Impact factor: 4.939

Review 8.  Biologically Targeted Magnetic Hyperthermia: Potential and Limitations.

Authors:  David Chang; May Lim; Jeroen A C M Goos; Ruirui Qiao; Yun Yee Ng; Friederike M Mansfeld; Michael Jackson; Thomas P Davis; Maria Kavallaris
Journal:  Front Pharmacol       Date:  2018-08-02       Impact factor: 5.810

9.  OBP-functionalized/hybrid superparamagnetic nanoparticles for Candida albicans treatment.

Authors:  Nicolò Riboni; Costanza Spadini; Clotilde S Cabassi; Federica Bianchi; Stefano Grolli; Virna Conti; Roberto Ramoni; Francesca Casoli; Lucia Nasi; César de Julián Fernández; Paola Luches; Maria Careri
Journal:  RSC Adv       Date:  2021-03-17       Impact factor: 3.361

10.  Augmenting regional and targeted delivery in the pulmonary acinus using magnetic particles.

Authors:  Yan Ostrovski; Philipp Hofemeier; Josué Sznitman
Journal:  Int J Nanomedicine       Date:  2016-07-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.